These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16781151)

  • 41. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
    Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
    Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology.
    Casoli T; Di Stefano G; Giorgetti B; Grossi Y; Balietti M; Fattoretti P; Bertoni-Freddari C
    Ann N Y Acad Sci; 2007 Jan; 1096():170-8. PubMed ID: 17405928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease Treatment.
    Schmidt M; Benek O; Vinklarova L; Hrabinova M; Zemanova L; Chribek M; Kralova V; Hroch L; Dolezal R; Lycka A; Prchal L; Jun D; Aitken L; Gunn-Moore F; Kuca K; Musilek K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
    Nishitomi K; Sakaguchi G; Horikoshi Y; Gray AJ; Maeda M; Hirata-Fukae C; Becker AG; Hosono M; Sakaguchi I; Minami SS; Nakajima Y; Li HF; Takeyama C; Kihara T; Ota A; Wong PC; Aisen PS; Kato A; Kinoshita N; Matsuoka Y
    J Neurochem; 2006 Dec; 99(6):1555-63. PubMed ID: 17083447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
    Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.
    Abdul-Hay SO; Edirisinghe P; Thatcher GR
    J Neurochem; 2009 Nov; 111(3):683-95. PubMed ID: 19702658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid beta protein-induced cytotoxicity.
    Kwak JW; Kim HK; Chae CB
    J Med Chem; 2006 Aug; 49(16):4813-7. PubMed ID: 16884292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.
    Cole DC; Stock JR; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jennings LD; Jin G; Lohse PA; Malamas MS; Manas ES; Moore WJ; O'Donnell MM; Olland AM; Robichaud AJ; Svenson K; Wu J; Wagner E; Bard J
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1063-6. PubMed ID: 18162398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualitative and quantitative characterization of the amyloid beta peptide (Abeta) population in biological matrices using an immunoprecipitation-LC/MS assay.
    Ford MJ; Cantone JL; Polson C; Toyn JH; Meredith JE; Drexler DM
    J Neurosci Methods; 2008 Mar; 168(2):465-74. PubMed ID: 18187205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease.
    Hook V; Kindy M; Hook G
    Biol Chem; 2007 Feb; 388(2):247-52. PubMed ID: 17261088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
    Zhang J; Mori A; Chen Q; Zhao B
    Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organofluorine inhibitors of amyloid fibrillogenesis.
    Török M; Abid M; Mhadgut SC; Török B
    Biochemistry; 2006 Apr; 45(16):5377-83. PubMed ID: 16618127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    He XY; Isaacs C; Yang SY
    J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amyloid beta (1-42) folding multiplicity and single-molecule binding behavior studied with STM.
    Ma X; Liu L; Mao X; Niu L; Deng K; Wu W; Li Y; Yang Y; Wang C
    J Mol Biol; 2009 May; 388(4):894-901. PubMed ID: 19328210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ; Zhou HD; Zhou XF
    Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.